Publication for COL1A2 and PDGFRB
| Species | Symbol | Function* | Entrez Gene ID* | Other ID | Gene coexpression |
CoexViewer |
|---|---|---|---|---|---|---|
| hsa | COL1A2 | collagen type I alpha 2 chain | 1278 | [link] | ||
| hsa | PDGFRB | platelet derived growth factor receptor beta | 5159 |
| Pubmed ID | Priority | Text |
|---|---|---|
| 31123405 | 0.98 | COL1A2, COL5A2, COL6A1, COL6A2, COL6A3, MMP9, THY1, TAGLN, VIM, CTGF, PDGFRB, ACTA2, SPP1, and TPM2 interacted closely with each other (Figure 1B). |
| 32058995 | 0.97 | COL1A2, BGN, COL5A2, THBS2, TIMP1, SPP1, PDGFRB, and COL4A1. |
| 0.94 | COL1A2, BGN, COL5A2, THBS2, TIMP1, SPP1, PDGFRB, and COL4A1 (Table 4). | |
| 0.81 | COL1A2, BGN, COL5A2, THBS2, TIMP1, SPP1, PDGFRB, and COL4A1 between GAC and normal gastric tissues in the GEPIA database. | |
| 0.61 | COL1A2, BGN, COL5A2, THBS2, TIMP1, SPP1, PDGFRB, and COL4A1 - were distinguished from the PPI network. | |
| 30850660 | 0.97 | Col1a2, TGF-beta1, and PDGFR-beta, in skin from patients with SSc (Fig. 1a). |
| 32194659 | 0.97 | PDGFRB, SERPINE1, SPARC, SFRP2, COL1A2, COL6A3, THBS2, COL5A2, COL11A1, FAP, MXRA5 and THY1 were upregulated in solid cancer tissues, and significantly associated with the overall survival of patients with cancer. |
| 27057137 | 0.96 | PDGFR-beta was significantly negatively correlated to COL4A6 as well as COL1A1 and COL1A2. |
| 29608729 | 0.95 | COL1A2, GAB2, GLI3, HDAC7, IFNGR1, LTF, MMP14, NCF2, NCF4, PDGFRA, PDGFRB, PIK3CB, TGFB1, TGFBI, TNFRSF11B, WWTR1), 2 genes between Cp and S (SOX2 and FSHR), and 2 genes between Cp and Cc (PIK3R1 and OCSTAMP). |
| 30816427 | 0.95 | COL1A2, DCN, COL3A1, FN1, MMP9, COL6A1, COL5A2, COL6A2, ITGA5, FBN1, CTGF, ITGA4, PDGFRB, LUM, PPIB, MMP14, ITGA11 and COPB1 (Table II). |
| 29913259 | 0.93 | COL1A2, collagen type II alpha 1 chain gene; COL3A1, collagen type III alpha 1 chain gene; COL5A1, collagen type V alpha 1 chain gene; COL5A2, collagen type V alpha 2 chain gene; Ctrl, control; FAP, fibroblast activation protein alpha gene; FC, fold change; FN1, fibronectin 1 gene; IGF1, insulin-like growth factor 1gene; MMP1, matrix metallopeptidase 1 gene; MMP2, matrix metallopeptidase 2 gene; MMP7, matrix metallopeptidase 7 gene; MMP8, matrix metallopeptidase 8 gene; MMP9, matrix metallopeptidase 9 gene; PDGFRA, platelet derived growth factor receptor alpha gene; PDGFRB, platelet derived growth factor receptor beta gene; Pt, patient; TGFB1, transforming growth factor beta 1 gene; TGFB2, transforming growth factor beta 2 gene; VEGFA, vascular endothelial growth factor A gene; VEGFB, vascular endothelial growth factor B gene. |
| 31214495 | 0.92 | COL1A2, OLFML2B, MMP2, FBN1, ADAM12, and PDGFRB). |
| 0.69 | COL1A2, OLFML2B, MMP2, FBN1, and PDGFRB) was highest in fibroblasts. | |
| 25678842 | 0.92 | Ialpha1, collagen type Ialpha2 and PDGFR-beta as well as alpha-SMA and TGF-beta1. |
| 26710118 | 0.91 | Col1a2 (collagen I), Col3a1 (collagen III), Tgf-beta1 (transforming growth factor-beta 1), Bmp-7 (bone morphogenetic protein-7), Pdgf-r (platelet-derived growth factor receptors, PDGF-R), Mmp-2, Mmp-13 (matrix metalloproteinases-2 and -13), Timp-1, -3 (tissue inhibitor of metalloproteinase-1 and -3) and (Fig. 3A). |
| 22493711 | 0.83 | COL1A2, COL3A1, FBN1, TNFAIP6, MMP2, GREM1, BGN, CDH11, SPOCK1, DCN, COPZ2, THY1, PCOLCE, PRRX1, PDGFRB, SPARC, INHBA, COL6A2, FN1, ACTA2. |
| 25552920 | 0.83 | PDGFRB and COL1A2 genes showed no statistically significant (NS) difference between the metastatic group and primary tumor group (Additional file 1: supplementary Figure 2). |
The preparation time of this page was 0.0 [sec].
